BORROWING VS. SCH's MAR FUNDING
Borrowing money from banks or ABL lenders:
- Adds debt to your balance sheet
- Ties up other assets
- Interest rates can vary since they are dependent
on the credit market
- Hidden fees
- Personal guarantees often required
- Lengthy application process, delaying the needed
cash infusion
- Credit limits and funding caps
- Restrictive terms
- Insufficient credit lines due to the often "under-valued"
valuation of assets, especially your A/R
- A loan repayment schedule which reduces the cash
available to use as working capital
|
SCH's MAR FUNDING PROGRAM:
- Debt-free working capital
- Improved cash flow
- Cash infusion within 24-48 hours of claim
submission to SCH
- Cost of funding does not vary with changing
interest rates
- Availability of funding grows with patient volume
without re-applying for additional financing
- Unrestricted use of funds to best meet your
financial and business needs
- Increased financial flexibility to use with other
financial tools since your assets are not used as collateral for a loan
- A healthier balance sheet which can reduce
the costs of borrowing while maintaining debt capacity
|
Healthcare organizations can reduce their dependency on borrowing as their sole form of financing by utilizing SCH's MAR Funding program. It can be customized to effectively work with your other financial tools to meet your fiscal requirements, whether they are short-term cash flow needs or long-term capital programs or whether you are in growth mode or fiscal stress. Since SCH's program provides a predictable and steady cash stream, not dependent on lagging reimbursements, your financial plans can be more effective in generating sufficient working capital that is less subject to the strains of fluctuating revenue cycles.
Healthcare executives - with the endorsement of their financial advisors - have found that by using SCH's MAR funding program, their medical receivables can be a productive asset rather than a cash flow obstacle to growth and profitability.
|